biote Corp.
biote Corp. Fundamental Analysis
biote Corp. (BTMD) shows moderate financial fundamentals with a PE ratio of 2.09, profit margin of 14.07%, and ROE of -35.31%. The company generates $0.3B in annual revenue with moderate year-over-year growth of 6.38%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 27.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze BTMD's fundamental strength across five key dimensions:
Efficiency Score
ExcellentBTMD demonstrates superior asset utilization.
Valuation Score
ExcellentBTMD trades at attractive valuation levels.
Growth Score
ModerateBTMD shows steady but slowing expansion.
Financial Health Score
ExcellentBTMD maintains a strong and stable balance sheet.
Profitability Score
WeakBTMD struggles to sustain strong margins.
Key Financial Metrics
Is BTMD Expensive or Cheap?
P/E Ratio
BTMD trades at 2.09 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, BTMD's PEG of -0.32 indicates potential undervaluation.
Price to Book
The market values biote Corp. at -0.97 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -0.11 times EBITDA. This is generally considered low.
How Well Does BTMD Make Money?
Net Profit Margin
For every $100 in sales, biote Corp. keeps $14.07 as profit after all expenses.
Operating Margin
Core operations generate 18.50 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-35.31 in profit for every $100 of shareholder equity.
ROA
biote Corp. generates $25.13 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
biote Corp. produces operating cash flow of $50.57M, showing steady but balanced cash generation.
Free Cash Flow
biote Corp. generates strong free cash flow of $43.09M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.98 in free cash annually.
FCF Yield
BTMD converts 36.75% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
2.09
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.32
vs 25 benchmark
P/B Ratio
Price to book value ratio
-0.97
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.42
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-1.88
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.22
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.35
vs 25 benchmark
ROA
Return on assets percentage
0.25
vs 25 benchmark
ROCE
Return on capital employed
0.57
vs 25 benchmark
How BTMD Stacks Against Its Sector Peers
| Metric | BTMD Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 2.09 | 28.96 | Better (Cheaper) |
| ROE | -35.31% | 716.00% | Weak |
| Net Margin | 14.07% | -46137.00% (disorted) | Strong |
| Debt/Equity | -1.88 | 0.35 | Strong (Low Leverage) |
| Current Ratio | 1.22 | 4.52 | Neutral |
| ROA | 25.13% | -17407.00% (disorted) | Strong |
BTMD outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews biote Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-60.37%
Industry Style: Defensive, Growth, Innovation
DecliningEPS CAGR
-96.72%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
-60.56%
Industry Style: Defensive, Growth, Innovation
Declining